These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 34117066)

  • 1. Combining generative artificial intelligence and on-chip synthesis for de novo drug design.
    Grisoni F; Huisman BJH; Button AL; Moret M; Atz K; Merk D; Schneider G
    Sci Adv; 2021 Jun; 7(24):. PubMed ID: 34117066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence to deep learning: machine intelligence approach for drug discovery.
    Gupta R; Srivastava D; Sahu M; Tiwari S; Ambasta RK; Kumar P
    Mol Divers; 2021 Aug; 25(3):1315-1360. PubMed ID: 33844136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design.
    Friedrich L; Cingolani G; Ko YH; Iaselli M; Miciaccia M; Perrone MG; Neukirch K; Bobinger V; Merk D; Hofstetter RK; Werz O; Koeberle A; Scilimati A; Schneider G
    Adv Sci (Weinh); 2021 Aug; 8(16):e2100832. PubMed ID: 34176236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generative Recurrent Networks for De Novo Drug Design.
    Gupta A; Müller AT; Huisman BJH; Fuchs JA; Schneider P; Schneider G
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29095571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generative artificial intelligence in drug discovery: basic framework, recent advances, challenges, and opportunities.
    Gangwal A; Ansari A; Ahmad I; Azad AK; Kumarasamy V; Subramaniyan V; Wong LS
    Front Pharmacol; 2024; 15():1331062. PubMed ID: 38384298
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Bung N; Krishnan SR; Bulusu G; Roy A
    Future Med Chem; 2021 Mar; 13(6):575-585. PubMed ID: 33590764
    [No Abstract]   [Full Text] [Related]  

  • 7. Generating and screening de novo compounds against given targets using ultrafast deep learning models as core components.
    Zhang H; Saravanan KM; Yang Y; Wei Y; Yi P; Zhang JZH
    Brief Bioinform; 2022 Jul; 23(4):. PubMed ID: 35724626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generative machine learning for de novo drug discovery: A systematic review.
    Martinelli DD
    Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Has Drug Design Augmented by Artificial Intelligence Become a Reality?
    Chen H; Engkvist O
    Trends Pharmacol Sci; 2019 Nov; 40(11):806-809. PubMed ID: 31629547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular
    Lin E; Lin CH; Lane HY
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32708785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors.
    Schneider G; Geppert T; Hartenfeller M; Reisen F; Klenner A; Reutlinger M; Hähnke V; Hiss JA; Zettl H; Keppner S; Spänkuch B; Schneider P
    Future Med Chem; 2011 Mar; 3(4):415-24. PubMed ID: 21452978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery.
    Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P
    Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. De novo molecular design and generative models.
    Meyers J; Fabian B; Brown N
    Drug Discov Today; 2021 Nov; 26(11):2707-2715. PubMed ID: 34082136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hit Identification Driven by Combining Artificial Intelligence and Computational Chemistry Methods: A PI5P4K-β Case Study.
    Wei L; Xu M; Liu Z; Jiang C; Lin X; Hu Y; Wen X; Zou R; Peng C; Lin H; Wang G; Yang L; Fang L; Yang M; Zhang P
    J Chem Inf Model; 2023 Aug; 63(16):5341-5355. PubMed ID: 37549337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New avenues in artificial-intelligence-assisted drug discovery.
    Cerchia C; Lavecchia A
    Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Learning Applied to Ligand-Based De Novo Drug Design.
    Palazzesi F; Pozzan A
    Methods Mol Biol; 2022; 2390():273-299. PubMed ID: 34731474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De Novo Design of Bioactive Small Molecules by Artificial Intelligence.
    Merk D; Friedrich L; Grisoni F; Schneider G
    Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29319225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generative chemistry: drug discovery with deep learning generative models.
    Bian Y; Xie XQ
    J Mol Model; 2021 Feb; 27(3):71. PubMed ID: 33543405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has Artificial Intelligence Impacted Drug Discovery?
    Patronov A; Papadopoulos K; Engkvist O
    Methods Mol Biol; 2022; 2390():153-176. PubMed ID: 34731468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence in drug design.
    Zhong F; Xing J; Li X; Liu X; Fu Z; Xiong Z; Lu D; Wu X; Zhao J; Tan X; Li F; Luo X; Li Z; Chen K; Zheng M; Jiang H
    Sci China Life Sci; 2018 Oct; 61(10):1191-1204. PubMed ID: 30054833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.